Meanwhile, the mRNA level of TGF‐β3 was significantly decreased in CAVD model compared to the control group, but markedly increased following the antagomiR‐29b treatment comparatively to the CAVD model group (P < .01, Figure 2). Here, TGFB3 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.